Continuing Clinical Trials under Covid-19

On 26 March 2020, Proventa International collaborated with ARENSIA on the first of a series of webinars looking at business continuity in the event of global pandemics. The webinar, which featured high levels of viewer engagement and a number of...

5 years ago
Clinical Development,Clinical Operations,News

Continuing Clinical Trials under Covid-19

On 26 March 2020, Proventa International collaborated with ARENSIA on the first of a series of webinars looking at business continuity in the event of global pandemics. The webinar, which featured high levels of viewer engagement and a number of...

5 years ago

Weekly News Round-up – 9/3/20

In the news this week, everyone’s talking about this thing called ‘coronavirus’, not sure if you’ve heard of it. Gilead are set to donate 1.5 million doses of remdesivir to sick patients, while the Gates Foundation is preparing to spend...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 9/3/20

In the news this week, everyone’s talking about this thing called ‘coronavirus’, not sure if you’ve heard of it. Gilead are set to donate 1.5 million doses of remdesivir to sick patients, while the Gates Foundation is preparing to spend...

5 years ago

Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 years ago

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

5 years ago

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

5 years ago
R&D,Clinical Development,Clinical Operations,News

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

5 years ago

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

5 years ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

5 years ago

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

5 years ago

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

5 years ago

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

5 years ago
Clinical Development,Clinical Operations,News

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

5 years ago

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

5 years ago